Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Conclusions: Lesion-targeted TULSA demonstrates accurate and safe ablation of PCa. A significant increase of post-TULSA non-perfused-volume was observed during 3 weeks follow-up concordant with necrosis on histology. TULSA achieved coagulation necrosis of all targeted tissues. A limitation of this treat-and-resect-study-design was conservative treatment near NVB in patients scheduled for RALP.
PMID: 31556779 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Tags: Scand J Urol Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Laparoscopy | Neurology | PET Scan | Prostate Cancer | Prostatectomy | Study | Toxicology | Ultrasound | Urology & Nephrology